jesse jacob

Professor of Medicine

Emory University

United States

Research Interests

Explore related searches

Professors in United States Professors in Microbiology Microbiology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jesse Jacob is a Professor of Medicine at Emory University in the United States. His research primarily focuses on topics related to antibiotic resistance, infection control, and clinical outcomes in hospital settings. Recent publications include studies on carbapenem-resistant Enterobacterales, electronic health record design influences, and the prevalence of COVID-19 among patients with multidrug-resistant infections.

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (12)

Susan Ray

Emory University School of Medicine

UNITED STATES

View details

Clare Rock

Associate Professor of Medicine.

Johns Hopkins University School of Medicine

UNITED STATES

View details

Kimberly Dukes

The University of Iowa

UNITED STATES

View details

Lindsey Gottlieb

Emory University

UNITED STATES

View details

Martin Krsak

University of Colorado School of Medicine

UNITED STATES

View details

Daniel J Diekema

The University of Iowa Roy J and Lucille A Carver College of Medicine

UNITED STATES

View details

David Weiss

Associate Professor

Emory University School of Medicine

UNITED STATES

View details

Ahmed Babiker

Emory University School of Medicine

UNITED STATES

View details

Zorana Matić

Visiting Associate Professor

Northeastern University

UNITED STATES

View details

Jason Gallagher

Temple University

UNITED STATES

View details

Meghan Maloney

UNITED STATES

View details

Daniel Uslan

University of California, Los Angeles

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

jesse jacob

Research Interests

Explore related searches

Contact this professor

About

Articles (23)

Identifying patients at high risk for carbapenem-resistant Enterobacterales (CRE) carriage on admission to acute care hospitals: validating and expanding on a public health model

Electronic Health Record Design Impacts Clinician Ordering Behavior: An Interrupted Time Series Analysis

Estimating the likelihood of hospitalists to repeatedly prescribe high rates of antibiotics

Proportion of carbapenem-resistant Enterobacterales with readily detectable beta-lactam resistance

Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales

Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study

Implementation of contact precautions for multidrug-resistant organisms in the post–COVID-19 pandemic era: An updated national Emerging Infections Network (EIN) survey

Implementing nasal povidone-iodine decolonization to reduce infections in hemodialysis units: a qualitative assessment

The role of the hospital bed in hospital-onset Clostridioides difficile: A retrospective study with mediation analysis

Rates of resistance and heteroresistance to newer β-lactam/β-lactamase inhibitors for carbapenem-resistant Enterobacterales

An observational study to determine the prevalence of COVID-19 among hospitalized patients with multidrug-resistant Enterobacterales infections and clinical outcomes, 10 U.S. Sites, 2020­–2022

Effect of an initial specimen diversion device on blood-culture contamination rates and vancomycin usage: A quasi-experimental study

Trends in Incidence of Carbapenem-Resistant Enterobacterales in 7 US Sites, 2016─2020

Evaluating indwelling devices and other risk factors for mortality in invasive Carbapenem-resistant Enterobacterales infections in Georgia, 2012–2019

The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative review

Healthcare design to improve safe doffing of personal protective equipment for care of patients with COVID-19

'Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance'-authors' response.

Clinical Impact of Ceftriaxone Resistance in <i>Escherichia coli</i> Bloodstream Infections: A Multicenter Prospective Cohort Study.

Development and evaluation of a structured guide to assess the preventability of hospital-onset bacteremia and fungemia

Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant Pseudomonas aeruginosa Collected through CDC’s Emerging Infections Program, United States, 2016–2018

Characteristics of community-acquired carbapenem-resistant Enterobacterales.

Clinical Decision Support Systems to Reduce Unnecessary Clostridioides difficile Testing Across Multiple Hospitals.

Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance.

Collaborators (12)

Susan Ray

Clare Rock

Kimberly Dukes

Lindsey Gottlieb

Martin Krsak

Daniel J Diekema

David Weiss

Ahmed Babiker

Zorana Matić

Jason Gallagher

Meghan Maloney

Daniel Uslan

Make your next move.

An observational study to determine the prevalence of COVID-19 among hospitalized patients with multidrug-resistant Enterobacterales infections and clinical outcomes, 10 U.S. Sites, 2020–2022